David Healey

VP Data Science at Enveda Biosciences. ML for drug discovery. Formerly at Recursion & MIT.

[David Healey @davidwhealey]

Metabolomics folks: if you're at #ASMS, stop by Enveda's posters to get sneak peeks of our impending data drop and our upcoming public CASMI small molecule identification competition!

Wednesday: WP 439 (Enveda-180 dataset)
hursday: ThP 341 (CASMI 2016)

[Robert Gehrke @RobertGehrke]

There is a LOT of stuff to unpack in Todd's thread here. So let's break it down, shall we?

It is true that about 220k people signed the petition. About 30% were invalid. Another ~9K removed their signatures.

That was the tally over about 100 days of signature gathering. The ..

[Nathan Benaich @nathanbenaich]

News! @modal_labs is supporting @RAAIS fellowships with $10,000 credits on their platform, alongside the $5,000 GPU credits from @LambdaAPI.

Working on AI-first, open source research outside big institutions?

Apply at airstreet(dot)com/fellowships

[David Healey @davidwhealey]

@useTMX Yes and yes

[David Healey @davidwhealey]

@bryan_gallion @NBCNews Yes and yes

[David Healey @davidwhealey]

Walking around the cathedral in #rouen around noon today and suddenly the spire was burning.

[David Healey @davidwhealey]

@useTMX Yes

[David Healey @davidwhealey]

@RevelateursFTV Yes

[David Healey @davidwhealey]

@nitsonnet Yes and yes. Thu 11 July 12:09 pm.

[David Healey @davidwhealey]

@EnexColm Yes

[David Healey @davidwhealey]

@Thomas_Hougaard Yes

[David Healey @davidwhealey]

@Helena_Skinner_ Yes I took it you may use it

[David Healey @davidwhealey]

@chrisrickett Yes

[Enveda @lifeschemistry]

Thank you to our friends over at @decodingbio for featuring PRISM, our foundation model for life's chemistry, in their latest newsletter.
To check out the excellent Decoding Bio newsletter: https://t.co/f0KIc88TeI

[David Healey @davidwhealey]

Mass spectrometry people, if you're at #ASMS this year, come see my talk at the Bruker eXceed symposium Multiomics breakout session Sunday at 12 noon, I'll be talking about our new PRISM foundation model.

[andrew blevins @Andrewdblevins]

Working on ML for Drug Discovery I have been frustrated with the size and/or quality of publicly available datasets to train and benchmark models with, so when my co-founder and I started our company we swore we would open-source some data as quickly as possible.

[Michael Bronstein @mmbronstein]

In a new post with @NaefLuca @vant_ai we ask what is needed for ML to succeed in biological problems and argue that it is necessary to move beyond "white-box data"
https://t.co/yE5uFPEof2

w inputs from @nathanbenaich @dom_beaini @befcorr @georg_e_winter @schwabpa @ggrigoryanv

[Nathan Benaich @nathanbenaich]

🪩The @stateofai 2023 is now here.

Our 6th installment is one of the most exciting years I can remember. The #stateofai report covers everything you *need* to know, covering research, industry, safety and politics.

There’s lots in there, so here’s my director’s cut 🧵